Printer-friendly version
FDA approval may spell trouble for Canadian patients

In 2022, the United States accounted for 42.6 per cent of pharmaceutical sales worldwide compared to 2 per cent for Canada.

Printer-friendly version

Question: Should patients in Rome or Detroit have faster access to new prescription drugs than someone living in Victoria or Windsor? If your answer to that is no, then here is another query: Why do government agencies tasked to approve or deny new drugs in Europe and the United States (and which presumably have the same high standards as Canada) act quicker when compared to Health Canada?